top of page
Browse by category
Search
No increased risk of mental health issues among those using semaglutide for weight loss
Taking the weight loss medication semaglutide does not increase the risk of depressive symptoms, suicidal thoughts or suicidal behaviour...
No association between GLP-1s and suicide
A study led by researchers at Karolinska Institutet, Sweden, has found there is no association between glucagon-like peptide-1 receptor...
Journal watch 4/09/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
REBORN study: How to prioritise patients for BMS leading to the appropriate selection
Improvements in the physical component of quality of life (QoL) after metabolic and bariatric surgery (MBS) varies for patients with...
Expansion of bariatric surgery in the UK ‘challenging’ due to significant upfront economic investment
Expanding the capacity of bariatric and metabolic surgery (BMS) capacity in England beyond a small proportion of the eligible population...
Pneumonia and respiratory causes the largest causes of long-term mortality after BMS
Pneumonia and respiratory causes were found to be the largest causes of long-term mortality after bariatric and metabolic surgery (BMS),...
Blocking circulating protein interferon-γ pathway could lead to potential treatment for metabolic liver disease
University of Massachusetts Medical School researchers have identified a novel pathway in the progression of metabolic liver disease that...
Semaglutide reduces COVID-19 related deaths in patients with obesity and CVD
Semaglutide reduced the rates of COVID-19-related adverse events, including death, in those who had overweight or obesity and established...
European Society of Cardiology Obesity Consensus Statement
The European Society of Cardiology (ESC) Clinical Consensus Statement on Obesity and Cardiovascular Disease, presented at this year's ESC...
BAPT prioritises patients most likely to gain greater benefits from surgery
The Bariatric Surgery Assessment and Prioritisation Tool (BAPT) prioritised those likely to gain greater benefits from surgery such as...
Browse by tag
bottom of page